1 / 6

Global Antidiabetics Market share worth over $116bn by 2023

For more details visit @ http://bit.ly/2jTItYg <br>Antidiabetics Market to be dominated by some notable industry participants includingTakeda, Merck, Boehringer Ingelheim, Oramed, Pfizer, Novo Nordisk, Eli Lilly and Sanofi Aventis.

jueekate
Download Presentation

Global Antidiabetics Market share worth over $116bn by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antidiabetics Market share to reach USD 116.1 billion by 2023: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights of Antidiabetics Market: • Geriatric demographic and obesity patients are likely to exhibit higher diabetes rates and will be the main drivers of this industry accounting for 360 million diabetes cases by 2023. • Diabetes as a global health concern is being addressed by the government through various campaigns to inform and educate people about the effects and consequences of this disease and thus, motivate them to take effective measures for its control. • For instance, NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) has organized educational campaigns like ‘Control your diabetes for life’,‘Small Steps’, etc. to spread awareness about the importance of diabetes control. • Multinational pharmaceutical companies like Pfizer, Merck, GlaxoSmithKline, Novartis, Eli Lilly, Sanofi, AstraZeneca are aiming towards expanding their market across 57.2 million people by 2025. • Expanding their respective product portfolios will be the major growth strategy adopted by these players over the coming years. Generic drug manufacturers will also witness high growth opportunities in this market taking advantage of the reliance factor on low cost medicines.

  3. Continued… • The Asia Pacific antidiabetics market is forecast to reach USD 28 billion by 2023. India and China are anticipated to be the revenue pockets due to high patient pool across these regions. • In addition to this, the regional growth will be fueled by increasing penetration rates of insulin analogs. The European market is estimated to register a CAGR of 9% from 2016-2023. The growth is mainly attributed to the large obese population in this region. • North America insulin antidiabetic market share worth USD 22.2 billion in 2015, will witness a noticeable surge in the coming years, driven by factors like better healthcare facilities in terms of accessibility, high disposable income, and favorable reimbursement policies. • Antidiabetics market is becoming highly competitive with a variety of industry participants entering into the business space. Generic drug manufacturers have high scope wherein they can drive the revenue by manufacturing biosimilar medicines.

  4. Europe Insulin Antidiabetics Market size, 2015 & 2023, (USD Million)

  5. Browse Full Market Research Report Antidiabetics Market @ http://bit.ly/2kPjtlE Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/185

  6. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related